Aspiriant LLC’s VanEck Morningstar Wide Moat ETF MOAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-13,415
Closed -$1.21M – 315
2024
Q1
$1.21M Buy
13,415
+4,785
+55% +$411K 0.05% 133
2023
Q4
$732K Hold
8,630
– – 0.03% 165
2023
Q3
$654K Buy
8,630
+3,875
+81% +$309K 0.03% 163
2023
Q2
$379K Buy
+4,755
New +$358K 0.02% 199

Other funds holding MOAT

Aspiriant LLC's MOAT Position: Q2 2024 in Review

Aspiriant LLC sold out of VanEck Morningstar Wide Moat ETF (MOAT) in Q2 2024, closing a stake of 13,415 shares — an estimated $1.21M sold.

Aspiriant LLC first reported a position in MOAT in Q2 2023 and held it in 4 quarters. The position peaked at $1.21M in Q1 2024. 660 funds tracked by Wall St. Rank hold MOAT as of Q2 2024.

  • Aspiriant LLC reported no remaining VanEck Morningstar Wide Moat ETF position as of Q2 2024 after selling out during the quarter.
  • Aspiriant LLC sold 13,415 VanEck Morningstar Wide Moat ETF shares in Q2 2024, an estimated $1.21M.
  • Aspiriant LLC first reported a position in VanEck Morningstar Wide Moat ETF in Q2 2023 and held it in 4 quarters.
  • Aspiriant LLC's VanEck Morningstar Wide Moat ETF position peaked at $1.21M in Q1 2024.
  • 660 funds tracked by Wall St. Rank held VanEck Morningstar Wide Moat ETF as of Q2 2024.

Based on Aspiriant LLC's 13F filing for Q2 2024, filed 15 Jul 2024.